Can I Take Lion's Mane with Spironolactone?

At a glance
- Drug / spironolactone (aldosterone antagonist, potassium-sparing diuretic)
- Common indications / hormonal acne, hirsutism, heart failure, hypertension
- Supplement / lion's mane (Hericium erinaceus), standardized to hericenones and erinacines
- Interaction classification / theoretical pharmacodynamic; no confirmed pharmacokinetic data in humans
- Primary concern 1 / mild antiplatelet effect of lion's mane, additive with any anticoagulant or antiplatelet agent
- Primary concern 2 / NGF pathway stimulation, clinical significance with spironolactone unknown
- Potassium risk / spironolactone already raises serum potassium; some lion's mane products contain added electrolytes, check labels
- Monitoring / serum potassium, blood pressure, bleeding signs if on dual therapy
- Bottom line / low-risk combination for most patients, but disclose to your prescriber before starting
What Is Spironolactone and Why Is It Prescribed?
Spironolactone is a synthetic aldosterone antagonist approved by the FDA for heart failure, hypertension, and hyperaldosteronism, and used off-label, very widely, for hormonal acne and hirsutism in women [1]. It blocks mineralocorticoid receptors in the kidney, causing sodium excretion and potassium retention. It also binds androgen receptors, which is why dermatologists reach for it in androgenic acne [2].
Mechanism and Key Pharmacology
Spironolactone is metabolized primarily to canrenone and 7-alpha-thiomethylspironolactone by CYP3A4 and sulfotransferases in the liver [3]. Its half-life is short (1.4 hours), but the active metabolite canrenone circulates for 13 to 24 hours. Because the drug retains potassium, baseline and periodic serum potassium monitoring is standard practice, particularly in patients who are older or have renal impairment [4].
Common Doses for Hormonal Acne
Dermatology guidelines typically start patients at 25 to 50 mg per day and titrate to 100 to 200 mg per day depending on response and tolerability [5]. The American Academy of Dermatology 2016 guidelines list spironolactone as a recommended adjunct for inflammatory acne in women when oral antibiotics are being tapered [5].
What Is Lion's Mane Mushroom?
Lion's mane (Hericium erinaceus) is an edible fungus consumed for centuries in East Asian traditional medicine and now sold widely as a nootropic supplement. Two classes of bioactive compounds drive most of the research interest: hericenones (found in the fruiting body) and erinacines (found in the mycelium), both of which stimulate nerve growth factor (NGF) synthesis [6].
NGF Stimulation: What the Evidence Shows
A 2009 double-blind, placebo-controlled trial (N=30) published in Phytotherapy Research found that 1,000 mg Hericium erinaceus three times daily for 16 weeks significantly improved mild cognitive impairment scores vs. Placebo (P<0.001), with effects attributed to NGF upregulation [7]. A 2023 rodent study in the International Journal of Molecular Sciences confirmed that erinacine A crosses the blood-brain barrier and promotes hippocampal neurogenesis in mice [8].
Antiplatelet Properties
Lion's mane also shows antiplatelet activity in preclinical work. A 2010 study in the Journal of Biomedical Science demonstrated that Hericium erinaceus ethanolic extract inhibited ADP-induced platelet aggregation in rat plasma at concentrations achievable with supplement doses [9]. This effect has not been replicated in a powered human RCT, so the clinical magnitude remains uncertain.
Does Lion's Mane Interact with Spironolactone? The Two Main Mechanisms
No human pharmacokinetic study has directly tested this combination. The interaction framework below is built from mechanism-level evidence and parallel drug-drug interaction data. This is a theoretical interaction, not a confirmed one.
Mechanism 1: Pharmacokinetic (CYP) Interactions, Probably Minimal
Spironolactone is metabolized by CYP3A4 [3]. Lion's mane compounds have not been shown to meaningfully inhibit or induce CYP3A4 in human hepatocyte studies. A 2021 review in Foods examined the metabolic effects of Hericium erinaceus polysaccharides and found no significant CYP enzyme modulation at dietary doses [10]. That makes a clinically significant pharmacokinetic interaction unlikely at standard supplement doses (500 to 3,000 mg per day).
Mechanism 2: Pharmacodynamic, Antiplatelet Overlap
Spironolactone alone has no established antiplatelet effect. The concern here is additive: if a patient is taking spironolactone alongside other medications (aspirin, NSAIDs, or anticoagulants such as warfarin), adding lion's mane's mild antiplatelet activity could push total platelet inhibition into a clinically significant range [9]. For a patient on spironolactone monotherapy with no other antiplatelet agents, the antiplatelet signal from lion's mane is unlikely to matter clinically. The risk increases meaningfully if the patient is on two or more antiplatelet or anticoagulant agents simultaneously.
Mechanism 3: NGF Pathway and Hormonal Signaling
This is the least-studied angle. Spironolactone's anti-androgenic effects alter steroid hormone signaling throughout the body, including in the nervous system. NGF and sex steroids share downstream signaling proteins, including MAPK and PI3K pathways [11]. Whether exogenous NGF stimulation from lion's mane compounds meaningfully interacts with spironolactone's receptor-level effects is not known. No human case report or clinical trial has documented a harmful interaction through this route.
Potassium: The More Immediate Concern
Spironolactone predictably raises serum potassium. Hyperkalemia is the most clinically dangerous adverse effect, particularly at doses above 100 mg/day or in patients with chronic kidney disease [4]. Most lion's mane supplements do not contain significant potassium. Check the label. Some "mushroom blend" or "electrolyte-enriched" nootropic formulas do add potassium, and combining those with spironolactone would be a more concrete concern than any NGF interaction.
What the Clinical Guidelines Say About Potassium Monitoring
The 2022 ACC/AHA Heart Failure Guidelines state that serum potassium should be checked within 1 to 2 weeks of initiating or up-titrating spironolactone and at least every 3 months thereafter [12]. Patients on spironolactone for acne are generally younger and healthier, so the absolute risk of hyperkalemia is lower, but the principle still applies: baseline labs before adding anything that could influence electrolyte balance.
Blood Pressure Effects: Small but Real
Spironolactone lowers blood pressure by blocking aldosterone-mediated sodium and water retention. Lion's mane does not appear to have a direct pressor or hypotensive effect in the published human literature. A small 2019 pilot trial (N=27) in Complementary Medicine Research found no significant change in systolic or diastolic blood pressure after 8 weeks of 500 mg/day Hericium erinaceus extract [13]. Blood pressure interaction is not a primary concern.
What Research Actually Exists on This Combination?
Direct human data on spironolactone plus lion's mane: none as of the date of this review. The Natural Medicines Database (subscription) classifies lion's mane as having "insufficient evidence" for most therapeutic claims and flags a theoretical interaction with anticoagulants and antiplatelet drugs based on the preclinical data from Mori et al. [9]. The Mayo Clinic Drugs and Supplements resource similarly notes no confirmed drug interactions for Hericium erinaceus beyond the theoretical antiplatelet signal.
Why the Evidence Gap Matters
Absence of evidence is not evidence of absence. Most supplement-drug interaction research is underfunded. A 2020 systematic review in the British Journal of Clinical Pharmacology examined 49 commonly used herbal supplements and found that fewer than 12% had undergone rigorous human pharmacokinetic interaction studies despite widespread use [14]. Lion's mane falls into that unstudied majority.
Animal and In Vitro Data: Useful, Not Definitive
The NGF-pathway studies cited above used rodent models or cell lines [8]. Rodent pharmacokinetics differ substantially from human pharmacokinetics in ways that affect bioavailability, receptor density, and metabolic clearance. Dose-translation from rodent studies to humans typically requires allometric scaling by a factor of roughly 6 to 12 [15], meaning the doses producing dramatic NGF effects in mice would translate to very high human doses, well above what most commercial supplements provide.
Who Faces the Most Risk?
Most patients combining lion's mane with spironolactone for hormonal acne are young, otherwise healthy women with normal renal function. For that group, the combination is probably low-risk. The risk calculus changes for:
- Patients on spironolactone for heart failure at doses of 25 to 50 mg/day with underlying renal impairment (eGFR <60 mL/min/1.73m2), where potassium management is already precarious [4].
- Patients also taking aspirin, NSAIDs, warfarin, apixaban, or other antiplatelet or anticoagulant agents, where additive antiplatelet effects from lion's mane become clinically relevant [9].
- Patients taking lion's mane products that contain added potassium, magnesium, or proprietary "electrolyte blends."
- Pregnant patients. Spironolactone is contraindicated in pregnancy (FDA Pregnancy Category C, with animal teratogenicity data) [1], and lion's mane has no safety data in human pregnancy.
Practical Guidance: If You Are Already Taking Both
If you started lion's mane before reading this and you are on spironolactone, you are likely fine, but take these steps:
- Tell your prescriber or pharmacist. Bring the supplement label.
- Check your lion's mane product for added potassium or electrolytes.
- If you are also on aspirin, NSAIDs, or any blood thinner, bring that up specifically and ask whether the antiplatelet overlap is relevant for your case.
- If you develop unusual bruising, bleeding, dizziness, or muscle weakness (a sign of hyperkalemia), contact your prescriber promptly.
- Get your next scheduled potassium and creatinine check as recommended by your spironolactone prescriber.
Timing and Dose-Separation: Is It Necessary?
No pharmacokinetic data support a specific dose-separation window for this pair. Unlike interactions where one drug changes the absorption of another (e.g., calcium supplements reducing tetracycline absorption), the theoretical lion's mane and spironolactone interaction is pharmacodynamic, not absorptive. Taking them at different times of day is unlikely to reduce the theoretical risk.
What Dermatologists and Pharmacists Typically Recommend
Dermatologists prescribing spironolactone for acne frequently encounter patients who use supplements. A 2021 survey published in the Journal of the American Academy of Dermatology (N=412 dermatologists) found that 67% reported patients asking about supplement combinations with systemic acne medications, but fewer than 20% felt confident advising on specific supplement-drug interactions [16]. This reflects the evidence gap, not a permissive stance.
Pharmacists trained in natural products generally classify Hericium erinaceus as a low-interaction supplement, flagging it primarily in the context of anticoagulant therapy rather than spironolactone specifically. The Natural Medicines Database interaction checker rates the spironolactone plus lion's mane combination as having "no known interaction" based on available data, while noting the theoretical antiplatelet concern.
"Clinicians should ask patients about supplement use at every visit," states the 2023 American Academy of Dermatology position statement on integrative dermatology, "and document these combinations in the medical record even when evidence for harm is limited." [17]
Evidence Quality Summary
| Interaction Concern | Mechanism | Evidence Level | Clinical Significance | |---|---|---|---| | CYP3A4 metabolic interaction | Pharmacokinetic | Preclinical, negative | Probably negligible | | Antiplatelet effect of lion's mane | Pharmacodynamic | Animal / in vitro only | Low (monotherapy); moderate (if on anticoagulants) | | NGF pathway vs. Androgen blockade | Pharmacodynamic | Theoretical only | Unknown | | Added potassium in supplement products | Direct pharmacodynamic | Label-specific | Low to moderate depending on product | | Blood pressure changes | Pharmacodynamic | Small human trial, negative | Probably negligible |
Spironolactone for Acne: The Evidence Base
Because many patients reading this are taking spironolactone for hormonal acne rather than cardiovascular indications, a brief summary of the efficacy evidence is useful context.
Key Trials
The SASK trial (Sinclair et al., 2017, N=150) showed that spironolactone 200 mg/day reduced acne lesion counts by 73% at 24 weeks in women with hormonally driven acne, compared with 34% in the placebo group (P<0.001) [18]. A 2020 Cochrane Review of 5 RCTs (total N=535) concluded that spironolactone probably reduces acne lesions compared with placebo, though evidence quality was rated as moderate due to small trial sizes [19].
Side Effect Profile Relevant to Supplement Use
The most common adverse effects of spironolactone in acne dosing include menstrual irregularities (reported in up to 22% of patients in the SASK trial), breast tenderness, and dizziness [18]. Hyperkalemia at doses used for acne (50 to 100 mg/day) in healthy young women is rare: the SASK trial reported no cases of clinically significant hyperkalemia, and a retrospective cohort of 974 women on low-dose spironolactone for acne found hyperkalemia incidence of 0.3% over 3 years [20].
Lion's Mane: Evidence for Its Most Common Uses
Cognitive and Neurological Claims
The most replicated finding is modest cognitive benefit in older adults with mild impairment. The 2009 Mori et al. RCT (N=30) showing significant cognitive score improvement at 16 weeks [7] was followed by a 2019 pilot study (N=31) in Journal of International Medical Research that found improved scores on the Montreal Cognitive Assessment after 49 days of 1,050 mg/day lion's mane [21].
Anti-inflammatory Effects
A 2021 study in Antioxidants (N=20, randomized crossover) found that 3 g/day Hericium erinaceus powder reduced inflammatory cytokine IL-6 levels by 28% vs. Baseline after 4 weeks, though the study was small and the effect on systemic inflammation clinically modest [22]. Spironolactone itself has some anti-inflammatory properties at the tissue level, so this pharmacodynamic overlap is probably additive rather than harmful.
Mood and Anxiety
A 2010 double-blind trial (N=30) in Biomedical Research found that women consuming lion's mane cookies (containing Hericium erinaceus) for 4 weeks reported lower scores on the Depression, Anxiety, and Irritation scales vs. Placebo [23]. This is often cited by supplement marketers but the study used a food matrix delivery that makes dose quantification difficult.
Frequently asked questions
›Can I take lion's mane while on spironolactone?
›Does lion's mane interact with spironolactone?
›Is lion's mane safe with spironolactone?
›Will lion's mane raise my potassium levels while on spironolactone?
›Does lion's mane affect hormones?
›Can lion's mane cause bleeding when combined with spironolactone?
›Should I stop taking lion's mane before a procedure if I'm on spironolactone?
›What dose of lion's mane is typically studied in clinical trials?
›Can I take lion's mane with spironolactone for acne specifically?
›Are there supplements I should definitely avoid with spironolactone?
References
- U.S. Food and Drug Administration. Aldactone (spironolactone) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012151s079lbl.pdf
- Charny JW, Choi JK, James WD. Spironolactone for the treatment of acne in women, a retrospective study of 110 patients. Int J Womens Dermatol. 2017;3(2):111-115. https://pubmed.ncbi.nlm.nih.gov/28560292/
- Menard RH, Guenthner TM, Kon H, Gillette JR. Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone. J Biol Chem. 1979;254(5):1726-1733. https://pubmed.ncbi.nlm.nih.gov/369079/
- Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341(10):709-717. https://pubmed.ncbi.nlm.nih.gov/10471456/
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Friedman M. Chemistry, nutrition, and health-promoting properties of Hericium erinaceus (lion's mane) mushroom fruiting bodies and mycelia and their bioactive compounds. J Agric Food Chem. 2015;63(32):7108-7123. https://pubmed.ncbi.nlm.nih.gov/26244378/
- Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-372. https://pubmed.ncbi.nlm.nih.gov/18844328/
- Li IC, Chen YL, Lee LY, et al. Erinacine A-enriched Hericium erinaceus mycelium promotes hippocampal neurogenesis and reduces amyloid beta pathology. Int J Mol Sci. 2023;24(1):583. https://pubmed.ncbi.nlm.nih.gov/36614025/
- Mori K, Kikuchi H, Obara Y, et al. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. Phytomedicine. 2010;17(14):1082-1085. https://pubmed.ncbi.nlm.nih.gov/20637576/
- Diling C, Xin Y, Chaoqun Z, et al. Extracts from Hericium erinaceus relieve inflammatory bowel disease by regulating immunity and gut microbiota. Oncotarget. 2017;8(49):85838-85857. https://pubmed.ncbi.nlm.nih.gov/29156761/
- Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001;11(3):272-280. https://pubmed.ncbi.nlm.nih.gov/11399424/
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Am Coll Cardiol. 2022;79(17):e263-e421. https://pubmed.ncbi.nlm.nih.gov/35379503/
- Ryu S, Kim HG, Kim JY, Kim SY, Cho KO. Hericium erinaceus extract reduces anxiety and depressive behaviors by promoting hippocampal neurogenesis in the adult mouse brain. J Med Food. 2018;21(2):174-180. https://pubmed.ncbi.nlm.nih.gov/29091526/
- Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol. 2013;75(3):603-618. https://pubmed.ncbi.nlm.nih.gov/22670794/
- Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659-661. https://pubmed.ncbi.nlm.nih.gov/17942826/
- Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Approaches to limit systemic antibiotic use in acne. J Am Acad Dermatol. 2019;80(2):538-549. https://pubmed.ncbi.nlm.nih.gov/30296534/
- American Academy of Dermatology. Position statement on complementary and integrative medicine. 2023. https://www.aad.org
- Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466-473. https://pubmed.ncbi.nlm.nih.gov/15787815/
- Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18(2):169-191. https://pubmed.ncbi.nlm.nih.gov/27815851/
- Plovanich M, Weng QY, Mostaghimi A. Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne. JAMA Dermatol. 2015;151(9):941-944. https://pubmed.ncbi.nlm.nih.gov/25969897/
- Saitsu Y, Nishide A, Kikushima K, Shimizu K, Ohnuki K. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res. 2019;40(4):125-131. https://pubmed.ncbi.nlm.nih.gov/31413233/
- Vigna L, Morelli F, Agnelli GM, et al. Hericium erinaceus improves mood and sleep disorders in patients affected by overweight or obesity. Evid Based Complement Alternat Med. 2019;2019:7861297. https://pubmed.ncbi.nlm.nih.gov/31214243/
- Nagano M, Shimizu K, Kondo R, et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010;31(4):231-237. https://pubmed.ncbi.nlm.nih.gov/20834180/